Adherex and NCI sign Exherin development deal
The National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), approved the collaboration with Adherex following their formal review of existing preclinical and
Novartis India has agreed to pay Rs12.5bn ($132m) to acquire the Minipres and Minipress trademarks in India, along with certain associated intellectual property rights, from Pfizer and Pfizer Products.